Skip to main content
. Author manuscript; available in PMC: 2019 Feb 5.
Published in final edited form as: Reg Anesth Pain Med. 2019 Jan;44(1):100–106. doi: 10.1136/rapm-2018-000007

Table 1.

Definitions and examples of complication categories.

Device-related complications
Migration Migration of any lead from the original placement site
Erosion Lead protruding through the skin
Lead damage Breakage, fracture, kink, or other damage
Damage to sheath Breakage, fracture, kink, or other damage
Lead connection failure Loose connection or disconnection
Hardware malfunction Battery failure, inoperable device, or IPG communication error
Difficult insertion Difficulty with lead placement
Difficult removal Difficulty with lead removal
Procedural complications
Neurologic symptoms New or worsened neurologic symptoms which most commonly involve numbness, paresthesias, weakness, or pain not including musculoskeletal back pain at entry points*
Dural puncture Visualized cerebrospinal fluid, suspected dural puncture, postdural puncture symptoms
Infection Infectious symptoms associated with non-prophylactic treatment
Hematoma Abnormal collection of blood
 Patient complaints
IPG site pain Abnormal patient-reported discomfort at IPG site
Unwanted stimulation Inappropriate or overstimulation, electrical shock-like sensations, or stimulation in an unwanted area
Surgically managed complications
Explant Removal of all implanted components
Revision Removal of any implanted component
Serious adverse event Epidural abscess, meningitis, seizure, asystole/cardiac arrest, stroke, death, neuraxial hematoma, admission to long-term rehabilitation, deep venous thrombosis, laminectomy/decompression surgery
Other Events not included in the above definitions
*

Not including symptoms which were stimulation related and ceased upon decreasing or eliminating stimulation.

Removal of trials leads was not considered an explant.

IPG, implantable pulse generator.